Comparative Effectiveness of Albumin vs No Albumin on Renal Replacement Therapy and Mortality in Patients With Septic Shock and Renal Impairment

ABOUT THIS EPISODE

Originally aired: April 1, 2025

CHEST April 2025, Volume 167, Issue 4

Asad E. Patanwala, PharmD, MPH, and Brian L. Erstad, PharmD, join CHEST^® Journal Podcast Moderator, Alice Gallo De Moraes, MD, FCCP, to discuss their research into the effect of albumin administration on the need for renal replacement therapy and mortality in patients with septic shock and renal impairment.

READ THE ARTICLE »

Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

Moderator
Alice Gallo De Moraes, MD, FCCP

Also available